Vertex Pharmaceuticals Incorporated (VX1.DE) XETRA

404.85

+5.3(+1.33%)

Updated at February 20 05:35PM

Currency In EUR

Valuation

Market Cap117.54B
Enterprise Value116.33B
P/E Ratio30.63
PEG Ratio3.85
Price/Sales Ratio10.06
Price/Book Ratio6.49
Enterprise/Revenue9.96
Enterprise/EBITDA24.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.33
Operating Margin0.35

Management Effectiveness

Return On Assets0.15
Return On Equity0.23

Income Statement

Revenue12.08B
Revenue/Share47.41
Gross Profit10.27B
EBITDA4.97B
Net Income3.95B
Diluted EPS15.33

Balance Sheet

Total Cash6.61B
Total Cash/Share26.04
Total Debt3.88B
Total Debt/Equity0.21
Current Ratio2.9
Book Value Per Share73.52

Price History

52-Week Change-12.62
52-Week High478.1
52-Week Low312.65
Moving Average 50 Days392.21
Moving Average 200 Days373.95

Statistics

Average Volume110
Shares Outstanding254.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A